Iceland vs Kazakhstan: Previously treated cases tested for RR-/MDR-TB
Iceland
100.0%
in 2022
Kazakhstan
100.0%
in 2024
Iceland rank
1st
Kazakhstan rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Iceland
- Kazakhstan
How they compare
Iceland currently reports 100.0% against 100.0% in Kazakhstan, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 2007 it was Kazakhstan ahead.
Iceland ranks 1st and Kazakhstan ranks 1st of 180 countries.
Across the 3 decades both report, Iceland averaged higher in 1 and Kazakhstan in 1.
Head to head by decade
| Decade | Iceland | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 75.0% | 50.0% | 25.0% | Iceland |
| 2010s | 62.5% | 89.8% | 27.2% | Kazakhstan |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Iceland or Kazakhstan?
- Iceland, at 100.0% against 100.0% in Kazakhstan as of 2022.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Iceland and Kazakhstan?
- 0.0%, with Iceland ahead.
- How many years of comparable data are there for Iceland and Kazakhstan?
- 7 years are reported by both, from 2007 to 2022.
- How do Iceland and Kazakhstan rank globally for previously treated cases tested for rr-/mdr-tb?
- Iceland ranks 1st and Kazakhstan ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.